(Q42285089)

English

Antihypertensive effects and pharmacokinetics of single and consecutive doses of cilazapril in hypertensive patients with normal or impaired renal function

scientific article published on January 1989

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

Antihypertensive effects and pharmacokinetics of single and consecutive doses of cilazapril in hypertensive patients with normal or impaired renal function (English)

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Shionoiri H

1

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

Gotoh E

2

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

Sugimoto K

3

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

Takasaki I

4

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

Minamisawa K

5

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

Ishii M

6

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

language of work or name

0 references

publication date

1 January 1989

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

27 Suppl 2

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

283S-287S

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

Enzyme immunoassay discrimination of a new angiotensin-converting enzyme (ACE) inhibitor, cilazapril, and its active metabolite

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379759

26 October 2017

The pharmacodynamics and dose-response relationships of the angiotensin converting enzyme inhibitor, cilazapril, in essential hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379759

26 October 2017

Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379759

26 October 2017

Effects of single doses of the converting enzyme inhibitor cilazapril in normal volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379759

26 October 2017

Pharmacokinetics and acute effect on the renin-angiotensin system of delapril in patients with chronic renal failure.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379759

29 May 2018

Blood concentration and urinary excretion of enalapril in patients with chronic renal failure.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379759

29 May 2018

Pharmacokinetics of the converting enzyme inhibitor cilazapril in normal volunteers and the relationship to enzyme inhibition: development of a mathematical model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379759

29 May 2018

Biological properties of the angiotensin-converting enzyme inhibitor cilazapril.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379759

29 May 2018

[Cilazapril in essential hypertension. A placebo-controlled double-blind study to establish the dosage]

1 reference

https://pubmed.ncbi.nlm.nih.gov/2527540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung

1 reference

https://pubmed.ncbi.nlm.nih.gov/2527540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New potent inhibitors of angiotensin converting enzyme

1 reference

https://pubmed.ncbi.nlm.nih.gov/2527540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2125.1989.TB03493.X

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42285089&oldid=2143905156"